MEwens
Social Media and Funding Brouhaha: Social media helped galvanize supporters of Planned Parenthood last week after Susan G. Komen for the Cure said it would cut off funding for the women’s health nonprofit — and then reversed its stance, the WSJ reports. According to social-media monitor NetBase Solutions, Komen-related chatter rose 80% from […]
Continued Read ...
MEwens
Bydureon, the once-weekly injection for treating patients with type 2 diabetes, has finally won the FDA’s okay.
As Dow Jones Newswires reports, it’s been a long, bumpy road to approval for the drug’s developer, Amylin Pharmaceuticals.
(Alkermes is behind the extended-release technology used to deliver the drug, a longer-acting version of Amylin’s twice-daily Byetta.)
Amylin started […]
Continued Read ...
MEwens
Seeking More Data: The FDA wants more information about an experimental diabetes drug from Bristol-Myers Squibb and AstraZeneca before considering it for approval, Dow Jones Newswires reports. The companies said the agency wants more clinical data in order to better assess the risks and benefits of dapagliflozin, which is a new type of […]
Continued Read ...
MEwens
Ending Dimebon Development: Pfizer and Medivation are ceasing development of Dimebon, an experimental Alzheimer’s treatment, the WSJ reports. It was the second phase 3 trial of the drug to fail. In 2008 Pfizer agreed to pay Medivation $225 million upfront plus up to an additional $500 million if milestones were met for development […]
Continued Read ...
MEwens
Paula Deen in her Today Show appearance.
Paula Deen — a celebrity chef known for high-calorie, high-fat recipes like this burger with bacon and eggs on a donut — has confirmed that she has type 2 diabetes.
In an interview with USA Today and a sit-down with Al Roker on the Today Show, Deen discusses […]
Continued Read ...
Laura Landro
Gut Brain: The health of the gut is tied to more than digestion, with links to processes and conditions including bone formation, learning and memory, Parkinson’s disease and, in lab rats, depression and anxiety, the WSJ reports. Researchers call the enteric nervous system the “gut brain” and note that about 95% of […]
Continued Read ...
Louise Radnofsky
$1,000 Genome in Sight?: Life Technologies will announce today a machine that — by the end of the year, the company says — will be able to map an individual’s complete genome for $1,000, and within a day, the WSJ reports. Right now the genome can be mapped for about $3,000 over […]
Continued Read ...
WSJ Staff
Testing blood-glucose levels without drawing blood may be part of a diabetics futuristic dream. But for now, patients might find helpful a new device just being introduced that allows test results to be transmitted instantly to a private online database, writes Personal Technology columnist Walt Mossberg in todays WSJ.
The device, a glucometer […]
Continued Read ...
MEwens
Even a small gap in Medicaid coverage can have consequences for diabetics, new research suggests.
The study looked at 3,384 diabetes patients who received medical care at 50 clinics in Oregon from 2005-2007. The care was mostly free, but some recommended diagnostic tests and other services — including cholesterol screening, HbA1c testing to determine […]
Continued Read ...
MEwens
We already know that the night shift may be hazardous to your health. And now, a new study finds that mixing up night shifts with day and evening work hours is associated with a higher risk of type 2 diabetes.
Published in PLoS Medicine, the analysis covers more than 177,000 women participating in two […]
Continued Read ...
Next Page »
|
|
|